HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children

Influenza and other Respiratory Viruses

Volumn 8, Issue 3, 2014, Pages 360-366

  Leahy, Timothy R ^a   Goode, Michelle ^a   Lynam, Paul ^a   Gavin, Patrick J ^a   Butler, Karina M ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

AS03 adjuvant; HIV; Pandemic H1N1 influenza; Vaccination

Indexed keywords

ANTIRETROVIRUS AGENT; INACTIVATED VACCINE; INFLUENZA VACCINE; SQUALENE; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ADJUVANT THERAPY; ADOLESCENT; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; DRUG FEVER; DRUG SAFETY; FEMALE; HEMAGGLUTINATION INHIBITION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA VACCINATION; INJECTION SITE PAIN; LOCAL SKIN REACTION; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; IRELAND; PRESCHOOL CHILD;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; IRELAND; MALE; PROSPECTIVE STUDIES;

EID: 84898026414     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12243     Document Type: Article

References (29)

1. Dawood FS, Subbarao K, Fiore AE. Influenza viruses; in Long SS, Pickering LK, Prober CG, (eds): Principles and Practice of Pediatric Infectious Diseases, 4th edn. Philadelphia: Elsevier, 2012; 1149-1159.
2. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680-689.
3. Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441-446.
4. Radwan HM, Cheeseman SH, Lai KK et al. Influenza in human immunodeficiency virus-infected patients during the 1997-1998 influenza season. Clin Infect Dis 2000; 31:604-606.
5. Klein MB, Lu Y, DelBalso L et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007; 45:234-240.
6. Cooper CL. Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity. Curr Opin Infect Dis 2012; 25:26-35.
7. Kok J, Tudo K, Blyth CC et al. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals. J Acquir Immune Defic Syndr 2011; 56:91-94.
8. Feiterna-Sperling C, Edelmann A, Nickel R et al. Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children. Clin Infect Dis 2010; 51:e90-e94.
9. Noguera-Julian A, Provens AC, Soler-Palacin P et al. Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children. Pediatr Infect Dis J 2011; 30:173-175.
10. Martinez E, Marcos MA, Hoyo-Ulloa I et al. Influenza A H1N1 in HIV-infected adults. HIV Med 2011; 12:236-245.
11. Riera M, Payeras A, Marcos MA et al. Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study. AIDS 2010; 24:2461-2467.
12. Peters PJ, Skarbinski J, Louie JK et al. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1) - United States, spring and summer 2009. Clin Infect Dis 2011; 52(Suppl 1):S183-S188.
13. Ormsby CE, de la Rosa-Zamboni D, Vazquez-Perez J et al. Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. AIDS 2011; 25:435-439.
14. Launay O, Desaint C, Durier C et al. Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. J Infect Dis 2011; 204:124-134.
15. Bickel M, von Hentig N, Wieters I et al. Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients. Clin Infect Dis 2011; 52:122-127.
16. Vigano A, Giacomet V, Pariani E et al. Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. Clin Vaccine Immunol 2011; 18:1503-1509.
17. Palma P, Romiti ML, Bernardi S et al. Safety and immunogenicity of a monovalent MF59(R)-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults. Biologicals 2012; 40:134-139.
18. Esposito S, Tagliaferri L, Daleno C et al. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Vaccine 2011; 29:1677-1682.
19. Phongsamart W, Sirisanthana V, Wittawatmongkol O et al. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine 2011; 29:8705-8711.
20. Strategic Advisory Group of Experts on Immunization - report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec 2009; 84:301-304.
21. Okike IO, Yung C, Ladhani S et al. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. Vaccine 2011; 29:6636-6640.
22. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133-138.
23. Tebas P, Frank I, Lewis M et al. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 2010; 24:2187-2192.
24. Evison J, Farese S, Seitz M et al. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 2009; 48:1402-1412.
25. de Carvalho AP, Dutra LC, Tonelli E. [Influenza vaccination in HIV infected children: immunologic and viral load changes]. J Pediatr (Rio J) 2003; 79:29-40.
26. Gunthard HF, Wong JK, Spina CA et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis 2000; 181:522-531.
27. Sullivan PS, Hanson DL, Dworkin MS et al. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS 2000; 14:2781-2785.
28. Macias J, Pineda JA, Leal M et al. HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. Eur J Clin Microbiol Infect Dis 2001; 20:46-48.
29. Skiest DJ, Machala T. Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol 2003; 26:307-315.